Fri, 20th Nov 2020 18:03
Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company - Announces grant of a patent for Alkindi by the European Patent Office. The patent provides in-market European protection until 2032 in all designated states of the European Patent Convention.
Current stock price: 52.00 pence
Year-to-date change: up 80%
By Arvind Bhunjun; arvindbhunjun@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hy...
(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommen...
